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Diet, the intestinal microbiota, and immune health in aging
Sarah J. Clementsa and Simon R. Cardinga,b
aGut Health & Food Safety Research Programme, Institute of Food Research, Norwich Research Park, Norwich, Norfolk, NR4 7UA; bNorwich Medical
School, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK
ABSTRACT
Many countries are facing aging populations, with those over 65 years of age likely to represent the largest
population over the next 10–20 years. Living longer often comes with poor health and, in particular, a
decline in the immune function characterized by poor vaccine responses and increased risk of infection
and certain cancers. Aging and diet represent major intrinsic and extrinsic factors that inﬂuence the
makeup and activity of resident intestinal microbes, the microbiota, the efﬁcient functioning of which is
essential for sustaining overall health and the effectiveness of the immune system. The provision of elderly
speciﬁc dietary recommendations appears to be lacking but is necessary since this population has an
altered microbiota and immune response and may not respond in the same way as their healthy and
younger counterparts. We have reviewed the evidence supporting the role of diet and, in particular,
dietary carbohydrate, protein, and fat in inﬂuencing the microbiota and its generation of key metabolites
that inﬂuence the efﬁcient functioning of immune cells during aging, and how dietary intervention might
be of beneﬁt in improving the intestinal health and immune status in the elderly.
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Introduction
The UK population is growing with increasingly more people
reaching the eighth decade of age and beyond (Christensen
et al., 2009). This is progressively becoming a problem since
these extra years of life are often accompanied by failing health
with elevated incidences of age-associated diseases such as type
II diabetes, cardiovascular disease, cancer, and increased risk of
infections causing inﬂuenza and pneumonia coupled with inef-
fective responses to vaccinations (Castle, 2000). This creates
problems of social care, healthcare, and the economy, with 72%
of social care requests received from people aged 65 years and
older between 2014 and 2015 (Health & Social Care Informa-
tion Centre, ASCST, 2015), implying that a large proportion of
these elderly citizens are not in good health. Between 2001 and
2011, the proportion of care home residents aged over 85 years
old increased in most regions in England and Wales, with the
highest increase of 13.2% seen in the East of England (ONS,
OFNS, 2014).
There is uncertainty regarding the deﬁnitions of aging and
aged and elderly populations, as aging encompasses both biologi-
cal and environmental factors in addition to chronological age.
According to the United Nations report of World Ageing
(DESA, UN, 2002), older people are classed as being 60 years or
older, with some studies classifying those aged over 85 years as
the “oldest old” (Wikby et al., 2002; Forsey et al., 2003). In con-
sidering different life expectancies in different countries, the clas-
siﬁcation of aged and elderly may differ widely across the globe
(Reques Velasco, 2008; Wilson et al., 2011; Wilson, 2014). For
the purpose of this review, the terms “aged” and “elderly” refer
to individuals aged 60 years and older, although some studies
referenced have used different deﬁnitions.
The age-related decline in overall health is accompanied by
immunosenescence and the progressive decline in immune
function, which has been associated with chronic low-grade
inﬂammation, termed as “inﬂammaging” (Franceschi et al.,
2007). Consistent with this description is the increased serum
levels of the pro-inﬂammatory cytokine IL-6 along with
increased intestinal permeability in elderly people (Man et al.,
2015). T cells are particularly affected by age, a key example
being the reduction in na€ıve CD8C T cells and the accumula-
tion of oligoclonal memory CD8C T cells (Khan et al., 2002;
Czesnikiewicz-Guzik et al., 2008). This reduction in na€ıve
CD8C T cells has been shown to correlate with impaired T cell
priming when compared to middle aged subjects (Brice~no
et al., 2016). Declining T cell functioning during aging is com-
pounded by a progressive decline in na€ıve T cell production by
the thymus. This process, termed as age-related thymic involu-
tion, starts from as early as the ﬁrst year of human life with the
loss of functional epithelium occurring at a rate of approxi-
mately 3% per year during adulthood (Taub and Longo, 2005;
Aw et al., 2009). Aging also affects B cells, although, perhaps,
not in the same way, or to the same extent as T cells (Scholz
et al., 2013). Whereas studies in mice provide evidence of
declining bone marrow haematopoiesis and B cell production
during aging, observations in humans suggest that B lympho-
poiesis is maintained well into old age. More consistent are the
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ﬁndings that humoral immune responses in aged mice and
humans are less robust and poorly protective compared with
those in young adults, although there may be wide variation
between individuals with environmental factors contributing to
this variability. Intrinsic B cell defects and the decline in pro-
duction of antibody to T cell-independent antigens in the
elderly accounts for their poor response to pneumococcal vac-
cines and the reliance of herd immunity and vaccinating chil-
dren to protect them against infection (Simonsen et al., 2011).
Aging also affects the motor and sensory functions of the
gastrointestinal (GI) tract, with the elderly having increased
susceptibility to GI complications of comorbid illnesses
(Rayner and Horowitz, 2013). Age-related changes in GI tract
function particularly affect the oesophagus and colon, with
reduced peristaltic pressure in the oesophagus leading to dys-
phagia and gastroesophageal reﬂux as well as reduction in the
motility of the colon, which can cause constipation (Grassi
et al., 2011). These symptoms alone may inﬂuence appetite or
swallowing ability, and thus affect the quantity and types of
food eaten, in addition to the loss of dentition with age, result-
ing in a reduced ability to chew food (Hickson, 2006). Aging
also affects resident intestinal microbes, the microbiota, with
striking changes in its makeup and composition being
described in elderly subjects (O’Toole and Brigidi, 2013). Utiliz-
ing fecal samples to interpret changes in populations within the
GI tract, and in particular the colon, it has been shown that
while the total number of bacteria remains fairly constant, the
different genera making up the microbiota change with age
(Woodmansey, 2007). Reductions in the proportion of bacter-
oides, clostridia, and total lactobacilli populations paralleled
with increases in fusobacteria, streptococci, and staphylococci
have been described in fecal samples from the elderly compared
with those from younger subjects (Woodmansey et al., 2004).
Higher levels of bacterial groups from the clostridium cluster
XIVa have similarly been described in microbiota proﬁles of
young and elderly subjects compared with that of centenarians,
with bacteroidetes having a lower relative contribution to the
microbiota of elderly compared with young individuals (Biagi
et al., 2010). The functional signiﬁcance of these or any other
changes in the relative abundance of speciﬁc bacterial popula-
tions, in view of the inherent complexity of the microbiota,
comprising more than 1000 species (Tremaroli and B€ackhed,
2012), and the interdependency of different bacteria, is difﬁcult
to discern. Of note, lower species diversity and a reduction in
Biﬁdobacteria in fecal samples of elderly subjects (aged
67–88 years) (Hopkins et al., 2002) corresponds with altered
functionality and the reduced ability of Biﬁdobacteria strains
from elderly subjects (aged 74–93 years) to adhere to intestinal
mucus (Ouwehand et al., 1999; He et al., 2001) compared to
strains isolated from younger age groups.
Alterations in the intestinal microbiota have potential die-
tary implications in considering the essential role it plays in
digestion and the efﬁcient conversion of complex plant polysac-
charides into short chain fatty acids (SCFAs) that provide a sig-
niﬁcant proportion of host’s daily energy needs and regulate
immune responses and inﬂammation (Marchesi et al., 2016). A
loss of carbohydrate fermenting bacteria or reduction in dietary
intake of plant-based polysaccharides often seen in the elderly
(Bartosch et al., 2004; Woodmansey et al., 2004) can lead to the
microbiota switching to other substrates, notably protein or
amino acids. The fermentation of amino acids, in addition to
releasing beneﬁcial SCFAs, produces a range of potentially
harmful compounds, of which ammonia, phenols, p-cresol, cer-
tain amines, and hydrogen sulﬁde can, in animal models, con-
tribute to intestinal diseases such as colon cancer or
inﬂammatory bowel disease (Windey et al., 2012). These ﬁnd-
ings highlight the need to consider carefully the dietary require-
ments of the elderly in terms of sustaining and promoting the
health of the GI tract and of its resident microbes. This review
will discuss how the diet affects the immune system, focusing
on the production of microbe-generated metabolites because of
food processing, and how this knowledge may be of use in
restoring gut health in the elderly.
The microbiota and its effect on the immune system
The colon is populated with more than 1 £ 1014 bacterial cells
and is dominated by the phyla ﬁrmicutes, bacteroidetes, actino-
bacteria, and proteobacteria, of which the ﬁrmicutes and bac-
teroidetes predominate (Maukonen and Saarela, 2015; Ple
et al., 2015). The microbiota is highly variable between individ-
uals, although there is an identiﬁable core that is independent
of gender, race, and age comprising approximately 55 species
that are common to >90% of individuals. This highly con-
served core encodes gene products unique to bacterial genomes
that are required for the degradation of complex plant-based
carbohydrates, and synthesis of SCFA and indispensable amino
acids and vitamins, highlighting the interdependency and
mutualistic relationship between the microbiota and its host
(Turnbaugh and Gordon, 2009; Qin et al., 2010; Arumugam
et al., 2011). Additional complexity is provided by the virome,
which contains the most abundant and fastest mutating genetic
elements (e.g. prophages and retroviruses) on earth (Reyes
et al., 2010; Minot et al., 2013; Virgin, 2014), in addition to pro-
tozoa and fungi with much less being known of the role that
these non-bacterial constituents play in promoting GI tract
health, or disease. The stability of intestinal microbiota is cen-
tral to maintaining the integrity of epithelial barrier and
immune homeostasis. Disruptions to this balance and resulting
dysbiosis are often associated with inﬂammation and compro-
mised barrier function, allowing microbiota constituents with
the potential to cause signiﬁcant disease (pathobionts) to trans-
locate the epithelium and to spread and infect other distant
sites of the body, with potentially catastrophic and fatal conse-
quences (Ple et al., 2015). The importance of intestinal micro-
biota for preserving health is further emphasized by sterile and
germ-free animals that suffer from nutritional deﬁciencies,
poor growth, increased intestinal permeability, a functionally
immature immune system, and altered neurochemical produc-
tion and brain development, all of which can be signiﬁcantly
overcome or reversed by microbial colonization and conven-
tionalization (Wostmann, 1981). The human intestinal micro-
biota is formed soon after birth and becomes fully established
within the ﬁrst decade of life, at which time it resembles the
complexity of the microbiota of adults (Palmer et al., 2007).
The intestinal microbiota is established in parallel with the
immune system, which is functionally immature in newborn
infants that become immunocompetent and able to mount































effective T and B cell responses by the time the microbiota is
fully established (Adlerberth and Wold, 2009). An important
factor in the efﬁcient development of both the intestinal micro-
biota and the immune system is early life nutrition, and the
positive effect that breastfeeding and breast milk has in helping
establish beneﬁcial Biﬁdobacteria, which can also modulate the
immune system (Fanaro et al., 2003; Solıs et al., 2010). Breast-
fed infants also exhibit reduced expression of genes encoding
products that can prime mucosal inﬂammatory responses,
including natural killer (NK) cell lectin-like receptors (KLRF1),
IL-1a, and arachidonate 5-lipoxygenase (Schwartz et al., 2012).
This highlights that the functioning and health of the GI tract,
the immune system, and the microbiota are closely interrelated
and that environmental factors, such as diet, can have inﬂuen-
tial effects on this important relationship, which is discussed in
more detail below.
Diet and the microbiota
A key example of the effect that diet has on shaping the micro-
biota is the divergent dietary patterns of children from rural
Africa and Europe, where Burkina Faso children consume up
to 14.2-g ﬁber per day and display strikingly different fecal
microbiota proﬁles compared with their European counterparts
that consume 8.4-g dietary ﬁber (De Filippo et al., 2010). Bur-
kina Faso children were exclusively colonized by Xylanibacter,
Prevotella, Butyrivibrio, and Treponema species, consistent
with their ability to utilize cellulose and xylose, present in plant
ﬁbers, for provision of energy and generation of SCFAs. Nega-
tive correlations between fecal concentrations of SCFAs and
intake of reﬁned grains and added sugar and positive correla-
tions between the intake of fruits and vegetables have also been
reported (Yang and Rose, 2014). In addition, increased intake
of dietary ﬁber (40 g) in healthy adults aged between 19 and
25 years has been associated with overexpression of genes
involved in methanogenesis and glycan and lipid metabolism,
when compared with lower ﬁber intake of 10 g, consistent with
increased fermentation as a result of higher levels of ferment-
able dietary ﬁber in the colon (Tap et al., 2015). A striking rela-
tionship between adherence to a Mediterranean (Med) diet and
abundance of fecal SCFAs has also been reported, which
strongly correlated with consumption of fruits, vegetables, and
ﬁber. This was accompanied with the prevalence of Prevotella
in plant-based diets, with metagenomic analysis revealing a sig-
niﬁcant increase in the abundance of genes associated with
polysaccharide degradation and SCFA metabolism (De Filippis
et al., 2015). In an elderly population (aged 65 years), where
subjects were fed with low fat and high ﬁber diet, greater diver-
sity in bacterial microbiota proﬁles were observed, while those
with “moderate to high” levels of fat and “low” ﬁber intakes
had the least diverse microbiota (Claesson et al., 2012). Collec-
tively, these studies show that intake of dietary ﬁber inﬂuences
the diversity of intestinal microbiota and the dominant species,
suggesting that a richly diverse microbiota may be beneﬁcial in,
for example, protecting against and excluding enteric patho-
gens that cause intestinal diarrhea-associated diseases. Of note,
in spite of poor sanitation and hygiene in Burkina Faso, species
of diarrhea inducing Enterobacteriaceae were underrepresented
(De Filippo et al., 2010).
Dietary ﬁber is not the only determinant of microbial species
diversity, as signiﬁcant reduction in Bacteroides and Biﬁdobac-
terium species are apparent in both vegetarians and vegans.
One comparative study showed a signiﬁcant reduction in
Enterobacteriaceae in vegans compared with omnivorous con-
trol subjects (Zimmer et al., 2012). However, this is inconsistent
with earlier, smaller scale studies, reporting greater proportions
of Lachnospira in vegetarians and vegans, compared with pre-
dominance of Clostridium in omnivores (Koeth et al., 2013).
Differing dietary patterns can be seen to affect the composition
of the microbiota with regard to the production of speciﬁc
metabolites. Consumption of protein-rich animal foods and fat
has been strongly associated with greater production of trime-
thylamine N-oxide (TMAO) from L-carnitine and phosphoti-
dylcholine in these foods with L. ruminococcus abundance (De
Filippis et al., 2015). High levels of TMAO in blood are associ-
ated with increased risk of cardiovascular disease, which is
thought to be a consequence of its negative effect on cholesterol
metabolism in the intestine, liver, and artery wall (Wilson et al.,
2013). Of note, TMAO, has been reported as being undetect-
able in the plasma or urine of long-term vegans after a meat
challenge, implying that the required gut microbes to produce
TMAO are absent or not present in sufﬁcient numbers within
the vegans’ microbiota (Koeth et al., 2013). This suggests that
long-established habitual dietary habits exert strong control
over the makeup of the microbiota, and occasional shifts in die-
tary habits, such as high (meat) protein intake in vegans/vege-
tarians, may not lead to the production of harmful metabolites.
The production of N-nitroso compounds from high meat con-
sumption that has been associated with elevated risk of colorec-
tal cancer, which can be suppressed by including soy protein in
high meat containing diets (Hughes et al., 2002), indicates that
it is important to consider the type of protein and the dietary
interactions that occur and the whole diet and not just one
component or nutrients in isolation.
The majority of dietary fats are absorbed in the small intes-
tine (Scott et al., 2013), although some can reach the colon
where these are metabolized by the microbiota as seen in stud-
ies assessing fecal recovery of radioactive carbon (14C) after
consumption of 14C-labeled lipids (Murphy et al., 1995;
Thompson and Spiller, 1995; Gabert et al., 2011). Conjugated
linoleic acid (CLA) is naturally present in red meat and dairy
products (O’Shea et al., 2004) and can also be produced by the
human intestinal microbiota (Coakley et al., 2003; Coakley
et al., 2009; Devillard et al., 2009; McIntosh et al., 2009; Gori-
ssen et al., 2010). The variable production of positional and
geometric isomers of CLA may affect health in different ways
with a comparison of two healthy individuals with different
biohydrogenation characteristics ﬁnding that bacterial metabo-
lism may inﬂuence the CLA isomers present. The subject hav-
ing a microbiota dominated by bacteroidetes had mostly
rumenic acid in their fecal sample, while the fecal samples of
the other subject with a microbiota dominated by Firmicutes
contained mostly trans-10,cis-12 linoleic acid (Devillard et al.,
2009). This may have signiﬁcant health implications since the
trans-10,cis-12 isomer of linoleic acid can negatively affect
blood lipid proﬁles (Tricon et al., 2004), and higher proportions
of Firmicutes have been observed in high fat feeding studies
(Ley et al., 2006; Turnbaugh et al., 2006). However, this is not































wholly consistent with the ﬁndings of other researchers (Dun-
can et al., 2008; Daniel et al., 2014) documenting the opposite
effect or no relationship at all.
While it is not yet fully understood how the microbiota
interacts with and modulates the immune system, direct activa-
tion of immune cells by microbial metabolites is a major focus
of current research activity.
Dietary metabolite effect on the immune system and
inﬂuence of the microbiota
According to various lines of investigation, three possible meta-
bolic pathways can produce bacterial metabolites that inﬂuence
the immune system with evidence of their effect in healthy
adults and elderly populations. The ﬁrst involves the produc-
tion of SCFA by bacterial fermentation of complex plant-based
polysaccharides, such as non-starch polysaccharides, resistant
starch, and oligosaccharides, in addition to gases such as hydro-
gen, carbon dioxide, and methane (Scott et al., 2013) (Fig. 1A).
These products of bacterial fermentation are thought to pro-
mote the establishment of regulatory T (Treg) cells that are
important for establishing and maintaining immune tolerance
as well as providing a source of energy for host cells. Although
it is difﬁcult to attribute the production of beneﬁcial metabo-
lites such as SCFA to particular members of the intestinal
microbiota, in the colon, members of the Clostridia genera that
are particularly abundant in the colonic mucosa have been
shown to be required for the generation of Treg cells (Atarashi
et al., 2011, 2013). Also, segmented ﬁlamentous bacteria, which
are prominent in the small intestine, have been shown to bind
intestinal epithelial cells (IECs) and provide them with SCFAs,
including butyrate (Hamer et al., 2008), which provides up to
85% of colonic epithelial cell energy requirements (Cultrone
et al., 2015). Although these ﬁndings provide documentary evi-
dence of the effect of dietary ﬁber-derived metabolites on Treg
cell induction in animal models (Arpaia et al., 2013; Furusawa
et al., 2013; Smith et al., 2013), extrapolating this to humans is
not straightforward, as the anatomy and physiology of the
mouse and human GI tract is not identical (Nguyen et al.,
2015). It is important, therefore, to validate the effects and out-
comes seen in mice in human intervention trials, which cur-
rently are very limited.
Some ex vivo studies using cultured human cells have shown
that provisions of SCFAs and butyrate have immunosuppressive
effects on antigen presenting cells and, in particular, dendritic
cells (DC) (Bohmig et al., 1997; Berndt et al., 2012; Liu et al.,
2012). Other in vitro model studies suggest that while SCFAs are
important, the plant ﬁbers themselves may have a direct effect
on immune cells and DCs in reducing pro-inﬂammatory cyto-
kine production and DC maturation (Bermudez-Brito et al.,
2015). These ﬁndings must, however, be interpreted with caution
since in vitro models cannot directly represent the in vivo situa-
tion, since other essential components of the intestinal mucosal
barrier, including mucus and the microbiota, are absent.
An in vivo study investigating the effect of probiotics and
prebiotics (galacto-oligosaccharides (GOS)) during pregnancy
and after birth has shown that the treated infants displayed
reduction in IgE-associated eczema and atopic eczema (Kukko-
nen et al., 2007). These ﬁndings were interpreted as a positive
effect of biotic therapy on the development of these diseases via
effects on the microbiota, since the GI tract of the supple-
mented infants was colonized with higher levels of beneﬁcial
lactobacilli and biﬁdobacteria. However, as this study primarily
focused on the probiotics provided to infants as opposed to co-
administered GOS, the observed effects may have been due to a
synergistic effect of both probiotics and prebiotic (synbiotics).
Similarly, provision of xylo-oligosaccharides and inulin has
been shown to increase fecal secretory IgA content and
increased levels of anti-inﬂammatory IL-13, while reducing
pro-inﬂammatory IL-1b in whole blood samples incubated
with bacterial lipopolysaccharide (LPS) (Lecerf et al., 2012).
These effects were associated with increased production of total
SCFA and reduced concentrations of p-cresol and acetate,
implying that the observed beneﬁcial immunomodulatory
effects were a direct result of these bacterial metabolites.
The second metabolic pathway involves protein-based
indigestible matter fermented by resident bacteria to pro-
duce phenols, ammonia, nitrates, and branched chain fatty
acids (BCFAs) as well as SCFA and gases (Fig. 1B). Some
of these metabolites can have detrimental effects on health
in promoting colonic inﬂammation and dysbiosis (Cultrone
et al., 2015). Interpreting the effects of these metabolites on
health is therefore complicated and compounded by con-
trasting effects of the same or different metabolites in dif-
ferent groups of individuals. No difference in immune
parameters or immune cell numbers was found when com-
paring consumption of a vegetarian versus meat-rich west-
ern diet in male athletes (Richter et al., 1991). However,
supplementing the diet of endurance athletes or adults car-
rying out intensive exercise with amino acids has been
shown to improve immune responses by preventing the
immune suppressive effects of elevated IL-1b and IFN-g,
decreased IL-10 (Kraemer et al., 2014), reduced lymphocyte
counts, increased levels of acute phase response proteins
(C-reactive protein (CRP)), and increased neutrophil counts
(Murakami et al., 2009) as observed in placebo groups.
Since endurance athletes display compromised immunity
and increased susceptibility to infections similar to the
immune status of elderly individuals, this data may be rele-
vant for an aging population. Signiﬁcantly increased oxida-
tive burst activity of monocytes and lymphocytes was
observed from ex vivo p-cresyl sulfate (pCS) administration
to whole blood samples, while p-cresol signiﬁcantly inhib-
ited these effects (Schepers et al., 2007), implying that
p-cresol suppresses monocyte and lymphocyte activation,
while its metabolite pCS may have a pro-inﬂammatory
effect. This is further implied, since reduction in p-cresol
levels was associated with increased fecal secretory IgA and
increased levels of IL-13 but reduced IL-1b in LPS-stimu-
lated whole blood samples (Lecerf et al., 2012). Supplement-
ing amino acid consumption with carbohydrates, such as
resistant starch, in human intervention studies has shown
reduction in the production of protein metabolites, includ-
ing phenols (Birkett et al., 1996). In contrast, another study
has shown that N-nitroso compounds and ammonia were
unaffected, although this study was underpowered and there
was substantial variability between subjects (Silvester et al.,
1997). On balance therefore, if excess fermentable































carbohydrate or resistant starch is present in addition to
any residual protein reaching the colon, its higher availabil-
ity may enable bacterial metabolism of SCFAs for example,
while the protein may provide an energy source for the
colonic bacteria.
The third pathway involves fatty acids reaching the colon,
typically of polyunsaturated fatty acid (PUFA) origin, which are
metabolized by the microbiota to produce CLA isomers
(Fig. 1C). The potential of the colon to contribute to fatty acid
absorption has not been studied in detail to date. Biﬁdobacterium
species can metabolize linoleic acid and a-linolenic acid to pro-
duce CLA and conjugated linolenic acid (CLnA) (Coakley et al.,
2003; Gorissen et al., 2010), although their overall effect on the
mucosal and systemic immune system is less clear. Of the limited
number of human studies carried out to date, most ﬁnd no dif-
ference in immune parameters after CLA supplementation (Kel-
ley et al., 2000, 2001; Albers et al., 2003; Tricon et al., 2004).
However, in one study, supplementation of CLA to human vol-
unteers was found to increase plasma IgA as well as IgM and
reduce IgE, in addition to reducing IFN-g, with the reduction
still apparent after the washout period (Song et al., 2005).
Another study using a higher dose of 3 g per day found a signiﬁ-
cant increase in mitogen-induced lymphocyte proliferation in
subjects supplemented with 80:20 cis-9,trans-11:trans-10,cis-12
(Nugent et al., 2005). In contrast, Albers et al. (2003) found no
signiﬁcant differences when comparing sunﬂower oil to a 50:50
or 80:20 mixture of cis-9,trans-11 and trans-10,cis-12 linoleic
acid. Although comparison of reference oil to 50:50 CLA supple-
mentation, and 50:50 to 80:20 CLA, revealed that twice as many
subjects produced sufﬁcient hepatitis B-speciﬁc antibodies (10
IU/L) in their serum to be considered protective against hepatitis
B infection, this did not reach statistical signiﬁcance. In a cross-
over study to determine whether these two main isomers have
differing effects, subjects were given capsules containing varying
doses of each isomer with no difference in immune function
being evident, although trans-10,cis-12 showed detrimental
effects on blood lipids (Tricon et al., 2004). Isomers aside, a
dose-dependent reduction in mitogen-induced T cell activation
was also observed along with signiﬁcant dose effects on TNF-a,
IL-1b, IFN-g, IL-10, and IL-5.
The consumption of high levels of both n-3 and n-6 PUFA
has also been be associated with reduction in secreted TNF
receptors (sTNFR1 and sTNFR2) in plasma but this effect is
only apparent with high intakes of n-3 PUFA. Without n-3
PUFA, n-6 PUFAs appear to be detrimental and elevate levels
Figure 1. Pictorial representation of key differences in the GI environment of
adults and elderly individuals in their response to the consumption of different die-
tary components. (A) Insoluble ﬁber reaching the colon is metabolized by the
microbiota to produce short chain fatty acids (SCFAs), such as butyrate, which can
affect local immune cells to alter cytokine secretion and T cell priming by dendritic
cells (DCs). In the elderly, consumption of ﬁber has been shown to have beneﬁcial
effects, although SCFA interaction with cells of the immune system can only be
implied. (B) Consumption of protein can lead to the production of p-cresylsulphate
(pCS) and p-cresol because of microbial metabolism; p-cresol appears to suppress
pro-inﬂammatory effects, while pCS has been shown to induce pro-inﬂammatory
effects. Evidence from the elderly shows that increased protein intake may
improve immune response to vaccination and reduce production of pro-inﬂamma-
tory mediators; however, it is unknown whether these effects are due to protein-
derived bacterial metabolites. (C) Consumption of n-3 and n-6 PUFAs or CLA has
been shown to reduce the secretion of pro-inﬂammatory cytokines and increase
the secretion of anti-inﬂammatory IL-10, in addition to increasing lymphocyte pro-
liferation. In an elderly population, it is not known whether CLAs) are involved,
although since CLAs regulate synthesis of prostaglandin E2 (PGE2), these may be
involved. Lymphocyte proliferation and neutrophil respiratory burst are affected
by n-3 and n-6 PUFA consumption, implying that quantities of fatty acid intake in
the elderly should be managed so as not to impair immune function. Abbrevia-
tions. AMPs: antimicrobial proteins; IESCs: intestinal epithelial stem cells; ILF: iso-
lated lymphoid follicle.































of sTNFR1 and sTNFR2 (Pischon et al., 2003), particularly in
men. While provision of n-3 PUFA has also been demonstrated
to have no effect on immune parameters of healthy adults
(Kew et al., 2003), in infants it has been associated with reduc-
tion in the incidence of allergies (Dunstan et al., 2003).
Dietary intervention to improve gut and immune
health in the elderly
Carbohydrate
The beneﬁcial immunoregulatory effects of increased
colonic Treg cell numbers and proliferation, as well as ele-
vated anti-inﬂammatory cytokines, observed in animal stud-
ies upon bacterial fermentation of dietary ﬁber to SCFAs
(Smith et al., 2013) together with the elevated production of
beneﬁcial SCFAs in adult human studies after increased
ﬁber intake could be targeted in elderly human subjects by
the consumption of adequate amounts of appropriate foods.
Increased fruit and vegetable intake signiﬁcantly increases
production of antibodies speciﬁc for pneumococcal capsular
polysaccharide, and the number of participants achieving a
four-fold increase in their antibody response to Pneumovax
II was signiﬁcantly increased when consuming ﬁve portions
per day (Gibson et al., 2012). The consumption of fructo-
oligosaccharides by elderly subjects was shown to reduce
IL-6 mRNA expression and phagocytic activity of granulo-
cytes and monocytes (Guigoz et al., 2002). Similarly, admin-
istration of beta-galacto oligosaccharides to elderly subjects
increased mononuclear cell phagocytosis in addition to NK
cell activity and production of IL-10 along with reduction
of IL-6, IL-1b, and TNF-a (Vulevic et al., 2008). Consump-
tion of prebiotic supplements (70% raftilose and 30% rafti-
line) by elderly subjects, however, had no effect on response
to inﬂuenza A vaccination (Bunout et al., 2002). On bal-
ance, therefore, the source, choice, and amount of dietary
ﬁber in the diet are to be carefully considered and
“matched” with the microbiota proﬁle and immune status
(health) of the person consuming them, which, as discussed
above, changes with age.
Protein
Studies conducted in healthy adults suggest that protein intake
changes the microbiota composition and its consumption
should be carefully monitored in order to be beneﬁcial and not
detrimental to health, noting that dietary protein intake and
amino acids are important energy substrates for immune cells
(Ruth and Field, 2013). When addressing an elderly population,
recommendations for protein intake should be considered care-
fully, since the US recommended daily amount (RDA) for
adults is 0.8 g protein per kg weight regardless of age, although
the elderly may beneﬁt from a higher protein intake (Campbell
et al., 2001; Wolfe et al., 2008). This is reinforced by the obser-
vation that elderly women consuming half of their daily protein
requirement for 9 weeks had a 50% reduction in their delayed
type hypersensitivity (DTH) response compared with their
baseline measure, while a protein intake of 2.94 g per kilogram
body cell mass per day, which is the RDA, achieved a 47%
increase in DTH reaction to dermally applied antigens. This
suggests that achieving the RDA of protein is a minimum
requirement for effective cell-mediated immune responses
(Castaneda et al., 1995). This is of particular interest as inter-
ventional or retrospective studies of elderly populations in Aus-
tralia (Zhu et al., 2010) and the United Kingdom (Bates et al.,
2014) imply that adults aged over 65 years had a lower intake
of meat than that by younger adults (Bates et al., 2014), and
with age people consume lower amounts of protein, when, in
fact, their requirements need to be more.
To date, there is little research on the effect of protein con-
sumption on immune response in an elderly population. How-
ever, a combination of resistance training and increased red
meat consumption by elderly women has been shown to reduce
serum levels of pro-inﬂammatory IL-6 by 16% (Daly et al.,
2014). Since elderly people may have a greater protein require-
ment to counterbalance muscle protein breakdown and achieve
an overall positive protein balance (Daly et al., 2015), the cur-
rent recommendations to reduce intake of red meat may be
misguided for elderly population.
The source of protein may also be relevant to immune health.
Whey protein in comparison to soymilk protein has been shown
to increase antibody response to pneumococcal vaccines, and in
particular to the four pneumococcal serotypes that cause the
most severe infections in adults (Freeman et al., 2010). However,
protein intake between the intervention and control groups in
this study was signiﬁcantly different when the supplement was
excluded, which may affect these ﬁndings. This is signiﬁcant, as
soy milk given to a group of postmenopausal women increased
B cell numbers (Ryan-Borchers et al., 2006), which is central to
considering vaccine antibody responses.
Fat
When studying the effect of PUFA, consideration must be given
to the speciﬁc population under investigation, and generaliza-
tion of health beneﬁts cannot be made, since an elderly popula-
tion may react differently. This is apparent when considering
the effect of eicosapentanoic acid (EPA) containing supplements
in old and young men, which showed that older men had
reduced neutrophil respiratory burst, which was further reduced
with increasing doses of EPA (Rees et al., 2006). Other observa-
tions also suggest a detrimental effect of ﬁsh oils on the aged
immune system, even in very low doses (Meydani et al., 1991;
Bechoua et al., 2003). It should be noted, however, that studies
reporting the use of very low doses, from 600 mg ﬁsh oil to 2.4 g
n-3 PUFA per day, translate to a greater consumption of ﬁsh
than the current UK recommendation of two portions per week
(Bates et al., 2012). Thus, the doses used in the studies referred
to exceed UK recommendations and are probably unachievable
through dietary intake when converted to actual ﬁsh intake
questioning the biological relevance of these ﬁndings. Other
ﬁndings imply a gender difference in immune effects. Observa-
tional data on the consumption of a-linolenic acid and linoleic
acid by semi-quantitative food frequency questionnaires
revealed no effect on the risk of developing pneumonia (Mer-
chant et al., 2005), while the observational data from a group of
women found the opposite (Alperovich et al., 2007).































High intakes of ﬁsh of four times per week had no effect on
serum cytokine levels in a group of healthy older Australians
(Grieger et al., 2014), suggesting that the lowering effect of
PUFA on inﬂammatory cytokines may only be apparent when
baseline inﬂammatory levels are high to start with. In addition,
a multi-ethnic study found that increased consumption of n-3
PUFA and all other non-fried ﬁsh was inversely associated with
IL-6, matrix metalloprotease protein-3, and CRP serum levels
(He et al., 2009). A reduction in lymphocyte proliferation with
increased intake of g-linoleic acid and EPA and DHA when
administered as capsules to older healthy subjects (Thies et al.,
2001) suggests that these PUFA may contribute to a reduction
in inﬂammation in these subjects. However, these effects were
only observed when EPA was combined with DHA, not with
DHA alone, implying that EPA mediates the observed anti-
inﬂammatory effects. Provision of g-linolenic and a-linoleic
acids from a non-ﬁsh source, blackcurrant seed oil, has demon-
strated an immune enhancing effect via greater induration of
DTH responses to tetanus toxoid in a group of elderly subjects
as well as a signiﬁcant reduction in prostaglandin E2 (PGE2)
serum levels (Wu et al., 1999). This is interesting since it has
been shown that synthesis of PGE2 is regulated by CLA, as
CLA administration to cultured human macrophages signiﬁ-
cantly reduced PGE2 production (Stachowska et al., 2009).
Therefore, CLA, a metabolite produced by intestinal microbiota
from consumption of PUFA, may reduce PGE2 concentrations
and help to reduce inﬂammation.
The EU-sponsored ELDERMET and Nu-AGE studies are
currently underway investigating the age-associated changes in
microbiota diversity of elderly individuals and changes in
immune parameters because of alterations in dietary intake,
respectively. These should provide valuable data and may assist
in understanding how dietary intake might inﬂuence outcomes
of the aging process, and whether parameters of immune func-
tion can be improved in elderly subjects.
Conclusions
More studies need to be carried out in aging models to under-
stand how bacterial metabolites important for human health
are produced in response to diet and the mechanisms by which
they act on the immune system during aging. Such studies are
made more difﬁcult and complicated by confounding factors
attributable to the aging process and changes in eating habits,
nutritional requirements, GI tract physiology, and the micro-
biota that must be taken into consideration when designing
such studies and interpreting the data obtained.
In addition, very few studies have investigated the effects of
changing the whole diet on the immune system. Some studies
have shown the effect of the Med diet on the immune system,
with decreases in plasma levels of hallmark indicators of
inﬂammation, including CRP, IL-6, IL-8, and TNF- a (Dedous-
sis et al., 2008; Mena et al., 2009), some of which are positively
associated with intake of red meat. These ﬁndings along with
those of others (Camargo et al., 2012) imply that the Med diet
has an anti-inﬂammatory effect, which could be a result of an
increase in SCFAs because of the elevated intake of fruit and
vegetables and whole grains, thus increasing the proliferation
of Treg cells. In addition, fat intake and its source is important
with the Med diet fat being derived from oily ﬁsh and olive oil,
which promote EPA and DHA synthesis along with production
of CLA isomers that may inhibit secretion of pro-inﬂammatory
eicosanoids and lipid mediators.
There is increasing evidence of a link between dietary intake
and changes in intestinal microbiota metabolism in the form of
metabolites, and that these metabolites can have effects on the
mucosal and/or systemic immune system. The clearest and the
most recognized ﬁndings to date comes from animal models
and the induction and expansion of Treg cells as a result of bacte-
rial fermentation of indigestible carbohydrates such as NSP.
There are currently insufﬁcient human intervention trials to cor-
roborate these ﬁndings. Other dietary effects on the immune
system are less clear, with implied positive effects of protein-
derivedmetabolites such as sulfur amines and BCFA from bacte-
rial fermentation on immune function. The effects of CLA iso-
mers on the immune system are also less established but the
data obtained to date are promising. More research is clearly
required to establish and prove these effects in both models of
aging and large-scale human intervention studies. This is espe-
cially important since the majority of the data available so far
relies on associations and/or is obtained from low powered
intervention studies due to small subject numbers. However, it
may be both timely and appropriate to suggest that the elderly
tailor their dietary intake to increase the consumption of dietary
ﬁber and manage protein intake so that recommended intakes
are, as a minimum, achieved, and the sources of fat intake be
considered so as not to include potentially deleterious quantities.
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